(Q73946512)
Statements
Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular t hypertension: a randomized clinical trial. Brimonidine Outcomes Study Group I (English)
J C Javitt
scientific article published on 01 June 2000